Rates of HIV antibody testing remain at approximately 45% of the general population. To more effectively design interventions to increase testing, comprehensive information is needed to understand the barriers to HIV testing. A measure of barriers to HIV testing was developed using the major barriers identified in the literature on barriers to health care utilization (Melnyk, 1988), and tested with a diverse group of individuals at high risk for HIV, including heterosexuals, men who have sex with men, injected drug users, and sex workers. An exploratory factor analysis indicated that the factor structure was replicated over 2 years of data collection. Three factors--Structural Barriers, Fatalism/Confidentiality Concerns, and Fear--emerged for both years. The reliabilities ranged from .75 to .87, indicating moderate to high internal consistency.

Download full-text PDF

Source
http://dx.doi.org/10.1521/aeap.16.2.115.29397DOI Listing

Publication Analysis

Top Keywords

barriers hiv
12
hiv testing
12
measure barriers
8
individuals high
8
high risk
8
barriers
6
hiv
5
testing
5
development measure
4
testing individuals
4

Similar Publications

Introduction: Dolutegravir (DTG) + lamivudine (3TC) demonstrated high rates of virologic suppression (VS) and low rates of virologic failure (VF), discontinuation, and drug resistance in randomized trials. Real-world evidence can support treatment effectiveness, safety, and tolerability in clinical practice and aid in treatment decisions.

Methods: A systematic literature review (SLR) was conducted to identify studies using DTG + 3TC (January 2013-March 2024).

View Article and Find Full Text PDF

Background: Women involved in the criminal legal system have elevated rates of opioid use disorder, which is treatable, and HIV, which is preventable with pre-exposure prophylaxis (PrEP). There are significant social and structural barriers to integrated delivery of PrEP and medications for opioid use disorder (MOUD), limiting women's ability to access these life-saving interventions. In a two parallel-arm randomized controlled trial, we are assessing an innovative eHealth delivery model that integrates PrEP with MOUD and is tailored to meet the specific needs of women involved in the criminal legal system.

View Article and Find Full Text PDF

Background: Black women living with HIV (WLHIV) often have suboptimal ART adherence due to a multitude of social and structural barriers, including HIV-related stigma. Trust in healthcare providers plays a significant role in adhering to ART and is likely lower among Black WLHIV compared to their White counterparts. This study examined the relationship between experienced stigma in healthcare settings and ART adherence and viral suppression through anticipated stigma in healthcare settings, internalized stigma, and medical mistrust.

View Article and Find Full Text PDF

Background: South Africa accounts for 14% of all new HIV infections representing the highest annual rate of new HIV infections globally. In addition, South Africa is home to 21% of the worldwide HIV burden, with 7.97 million people living with HIV.

View Article and Find Full Text PDF

Introduction: The Joint United Nations Programme on HIV/AIDS (UNAIDS) Global 2025 targets prioritize action to overcome the collective barriers affecting the people and communities sitting on the outer margins of HIV care. Addressing the social and structural disparities that drive greater HIV prevalence and burden requires well-resourced, community-led responses that are fully integrated into national and global HIV initiatives.

Methods: The HIV Community Council (HCC), composed of 10 leaders from diverse global communities, convened to share their insights, amplify the community's voice, and identify barriers and solutions to empower all to live well with HIV through a dynamic, stepwise process of preparative work, deep discussion, prioritization, and consensus.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!